2020-12-16,Ovid Therapeutics Announces Addition to the Nasdaq Biotechnology Index
2020-12-16,Is OVID A Good Stock To Buy Right Now?
2020-12-02,Why Ovid Therapeutics Stock Is Imploding Today
2020-12-02,"Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Ovid Therapeutics Inc. (OVID) Investigation"
2020-12-02,"Benzinga's Top Upgrades, Downgrades For December 2, 2020"
2020-12-02,"The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod"
2020-12-01,Ovid Therapeutics Announces Phase 3 NEPTUNE Clinical Trial of OV101 for the Treatment of Angelman Syndrome Did Not Meet Primary Endpoint
2020-11-25,Are Options Traders Betting on a Big Move in Ovid Therapeutics (OVID) Stock?
2020-11-23,Ovid Therapeutics to Present at the American Epilepsy Society (AES)  2020 Virtual Congress
2020-11-16,These Analysts Think Ovid Therapeutics Inc.'s (NASDAQ:OVID) Sales Are Under Threat
2020-11-12,Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
2020-10-14,Ovid Therapeutics to Host Educational Webinar on Angelman Syndrome and OV101 Development Program
2020-10-12,Ovid Therapeutics to Present at the Child Neurology Society/International Child Neurology Association (CNS/ICNA) Virtual Congress
2020-10-05,Opthea to Appoint Dr Jeremy Levin as Chairman of the Board
2020-09-30,Ovid Therapeutics Provides Soticlestat (OV935/TAK-935) Results from ARCADE and ENDYMION Studies Showing Seizure Reduction in Rare Epilepsies
2020-09-11,Ovid Therapeutics to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
2020-08-25,Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock
2020-08-25,Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint Reducing Seizure Frequency in Children with Dravet Syndrome or Lennox-Gastaut Syndrome
2020-08-25,Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint Reducing Seizure Frequency in Children with Dravet Syndrome or Lennox-Gastaut Syndrome
2020-08-10,Ovid Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
2020-08-05,Ovid Therapeutics to Participate at the William Blair Biotech Focus Conference 2020
2020-07-25,3 Top Biotech Stocks to Buy Now
2020-07-23,Ovid Therapeutics and University of Connecticut Enter into Strategic Research Collaboration to Accelerate the Development of Next-Generation Genetic Therapy for Angelman Syndrome
2020-07-14,Is Ovid Therapeutics Stock a Buy?
2020-07-13,"Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe"
2020-07-13,How Much Of Ovid Therapeutics Inc. (NASDAQ:OVID) Do Insiders Own?
2020-07-13,"Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe"
2020-07-08,Is Ovid Therapeutics Inc. (OVID) Going to Burn These Hedge Funds?
2020-06-29,Ovid Therapeutics Added to Russell 2000® and Russell 3000® Indexes
2020-06-25,Ovid Therapeutics (OVID) Jumps: Stock Rises 12.4%
2020-06-22,Implied Volatility Surging for Ovid Therapeutics (OVID) Stock Options
2020-06-19,Ovid Therapeutics Receives FDA Rare Pediatric Disease Designation for OV101 for the Treatment of Angelman Syndrome
2020-06-11,Ovid Therapeutics Announces Strategic Research Collaboration Focused on Accelerating the Development of New Treatments for Rare Neurological Diseases
2020-06-08,Ovid Therapeutics Announces Multiple Presentations on the 2020 American Academy of Neurology Science Highlights Platform
2020-06-04,Ovid Therapeutics Launches Pipeline Teach-In Webinar Series
2020-05-12,Ovid Therapeutics Announces Participation in the 2020 RBC Capital Markets Virtual Global Healthcare Conference
2020-05-07,Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
2020-05-07,Ovid Therapeutics Announces Positive Topline Results from the Phase 2 ROCKET Trial of OV101 for the Treatment of Fragile X Syndrome
2020-04-22,Top Ranked Momentum Stocks to Buy for April 22nd
2020-04-09,How Much Are Ovid Therapeutics Inc. (NASDAQ:OVID) Insiders Spending On Buying Shares?
2020-03-30,Ovid Therapeutics Announces Initial Data with Soticlestat in CDKL5 Deficiency Disorder and Dup15q Syndrome
2020-03-11,"Ovid Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update for 2020"
2020-03-05,Ovid Therapeutics Announces Multiple Presentations at the American Academy of Neurology 2020 Annual Meeting
2020-03-02,"Ovid Therapeutics Names Alexander Kolevzon, M.D., to Scientific Advisory Board"
2020-02-25,Ovid Therapeutics to Present at the Cowen and Company 40th Annual Health Care Conference
2020-01-23,"Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments"
2020-01-21,Pharma Company Buybacks: Do They Really Benefit Shareholders?
2020-01-10,Is Ovid Therapeutics (NASDAQ:OVID) In A Good Position To Invest In Growth?
2020-01-07,Ovid Therapeutics Provides 2020 Update in Preparation for Multiple Clinical Data Readouts Across Rare Neurological Disease Platform
2019-12-19,Hedge Funds Have Never Been More Bullish On Ovid Therapeutics Inc. (OVID)
2019-12-06,RBC: 3 Strong Buy Stocks That Could Step on the Gas in 2020
2019-11-26,Ovid Therapeutics to Participate at the 31st Annual Piper Jaffray Healthcare Conference
2019-11-18,Ovid Therapeutics Appoints Jason Tardio as Chief Commercial Officer
2019-11-08,Ovid Therapeutics Reports Third Quarter 2019 Financial Results and Recent Progress
2019-11-01,Ovid Therapeutics Announces Senior Management Promotions in Preparation for Multiple Data Readouts Expected in 2020
2019-10-16,Will Ovid Therapeutics Continue to Surge Higher?
2019-10-12,Jeremy Levin Is The Chairman & CEO of Ovid Therapeutics Inc. (NASDAQ:OVID) And They Just Spent US$150k On Shares
2019-10-11,"Ovid Therapeutics, Sunrun, Pure Cycle, and Other 13D Filings"
2019-10-04,Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
2019-10-04,Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
2019-10-04,"The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering"
2019-10-03,Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
2019-09-24,Will Ovid Therapeutics Continue to Surge Higher?
2019-09-23,Ovid Therapeutics Announces Positive Initial Data from Ongoing ENDYMION Open-Label Extension Trial of Soticlestat in People with Rare Epilepsies
2019-09-20,Could The Ovid Therapeutics Inc. (NASDAQ:OVID) Ownership Structure Tell Us Something Useful?
2019-09-12,Ovid Therapeutics Announces First Patient Randomized in Pivotal Phase 3 NEPTUNE Trial of OV101 for the Treatment of Angelman Syndrome
2019-09-09,Ovid Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
2019-09-03,Ovid Therapeutics Announces Participation in Two Upcoming Investor Conferences
2019-08-07,Ovid Therapeutics Reports Second Quarter 2019 Financial Results and Highlights Recent Progress
2019-07-09,Some Ovid Therapeutics (NASDAQ:OVID) Shareholders Have Taken A Painful 71% Share Price Drop
2019-07-02,Ovid Therapeutics Receives Orphan Drug Designation from the European Commission for OV101 for the Treatment of Angelman Syndrome
2019-06-27,Ovid Therapeutics Initiates Pivotal Phase 3 Clinical Trial in Angelman Syndrome; Multiple Data Readouts Across Rare Neurological Disease Pipeline Expected in 2H 2019 and Early 2020
2019-06-18,"Ovid Therapeutics to Host R&D Day on June 27, 2019"
2019-05-23,Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium
2019-05-07,Ovid Therapeutics Reports First Quarter 2019 Financial Results
2019-05-06,Ovid Therapeutics Rallies On Rare Genetic Disorder Drug Data
2019-04-27,Have Insiders Been Buying Ovid Therapeutics Inc. (NASDAQ:OVID) Shares This Year?
2019-04-18,Ovid Therapeutics to Present at the American Academy of Neurology 71st Annual Meeting
2019-03-28,Ovid Therapeutics Announces Senior Management Changes to Align Expertise with Advancing Clinical Stage Pipeline
2019-03-21,"Ovid Therapeutics Announces Appointment of Pharmaceutical Veteran, Thomas Perone, as Senior Vice President, General Counsel and Corporate Secretary"
2019-03-07,Ovid Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
2019-03-04,"Ovid Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference on Monday, March 11"
2019-02-20,Why A Secondary Offering Is Often Negative For Stocks
2019-02-20,Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
2019-02-20,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering"
2019-02-19,Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
2019-02-07,Zynerba Stock Is Marijuana-Adjacent Play Worth a Look
2018-12-25,How Much Of Ovid Therapeutics Inc. (NASDAQ:OVID) Do Insiders Own?
2018-12-17,Ovid Therapeutics Announces Phase 1b/2a Results of OV935/TAK-935 in Adults with Rare Epilepsies
2018-12-06,Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome
2018-11-20,Ovid Therapeutics Announces OV935/TAK-935 Presentations at the American Epilepsy Society 72nd Annual Meeting
2018-11-16,"Granite Point Capitals Returns, AUM, and Holdings"
2018-11-14,"Ovid Therapeutics to Present at 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27"
2018-11-08,Ovid Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Recent Clinical Progress
2018-10-25,Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101 for the Treatment of Angelman Syndrome at the 65th AACAP Annual Meeting
2018-10-22,Ovid Therapeutics Receives Company Making a Difference Award from CDKL5 Deficiency Disorder Community
2018-10-22,"Ovid Therapeutics to Host Conference Call and Webcast on Thursday, October 25, at 10:30 a.m. EDT"
2018-09-24,Ovid Therapeutics Announces Initiation of Two Phase 2 Clinical Trials of OV935/TAK-935 for Pediatric Patients with Rare Epilepsies
2018-09-19,Ovid Therapeutics to Present at Two Investor Healthcare Conferences in October 2018
2018-09-05,OVID THERAPEUTC Sees Hammer Chart Pattern: Time to Buy?
